Myelogenous leukemia

Myelogenous leukemia (pronounced: my-uh-loj-uh-nuhs loo-kee-mee-uh), also known as myeloid leukemia or granulocytic leukemia, is a type of cancer that originates in the bone marrow and affects the white blood cells. The term "myelogenous" (pronounced: my-uh-loj-uh-nuhs) is derived from the Greek words "myelos" meaning marrow and "genes" meaning producing.

Types

There are two main types of myelogenous leukemia:

Chronic myelogenous leukemia (CML): This type of leukemia typically affects adults and progresses slowly over many years.
Acute myelogenous leukemia (AML): This is a rapidly progressing form of leukemia that can occur in individuals of any age, but is most common in adults.

Symptoms

Symptoms of myelogenous leukemia can vary depending on the type and stage of the disease. Common symptoms include fatigue, fever, weight loss, and frequent infections.

Causes

The exact cause of myelogenous leukemia is unknown. However, it is believed to be caused by mutations in the DNA of blood cells. These mutations cause the cells to grow and divide at an abnormal rate, leading to the development of leukemia.

Treatment

Treatment for myelogenous leukemia can include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. The choice of treatment depends on the type and stage of the disease, as well as the patient's overall health.

Prognosis

The prognosis for myelogenous leukemia can vary greatly depending on a number of factors, including the type and stage of the disease, the patient's age and overall health, and the response to treatment.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Myelogenous leukemia